CN120835873A - 还原型辅酶q10结晶及制剂 - Google Patents

还原型辅酶q10结晶及制剂

Info

Publication number
CN120835873A
CN120835873A CN202480019999.6A CN202480019999A CN120835873A CN 120835873 A CN120835873 A CN 120835873A CN 202480019999 A CN202480019999 A CN 202480019999A CN 120835873 A CN120835873 A CN 120835873A
Authority
CN
China
Prior art keywords
crystals
reduced coenzyme
melting point
preparation
crystal
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN202480019999.6A
Other languages
English (en)
Chinese (zh)
Inventor
桥本贵识
山口贵生
谷崎昴
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Kaneka Corp
Original Assignee
Kaneka Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kaneka Corp filed Critical Kaneka Corp
Publication of CN120835873A publication Critical patent/CN120835873A/zh
Pending legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C43/00Ethers; Compounds having groups, groups or groups
    • C07C43/02Ethers
    • C07C43/20Ethers having an ether-oxygen atom bound to a carbon atom of a six-membered aromatic ring
    • C07C43/23Ethers having an ether-oxygen atom bound to a carbon atom of a six-membered aromatic ring containing hydroxy or O-metal groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
CN202480019999.6A 2023-03-30 2024-03-27 还原型辅酶q10结晶及制剂 Pending CN120835873A (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2023056001 2023-03-30
JP2023-056001 2023-03-30
PCT/JP2024/012301 WO2024204380A1 (ja) 2023-03-30 2024-03-27 還元型補酵素q10の結晶及び製剤

Publications (1)

Publication Number Publication Date
CN120835873A true CN120835873A (zh) 2025-10-24

Family

ID=92905592

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202480019999.6A Pending CN120835873A (zh) 2023-03-30 2024-03-27 还原型辅酶q10结晶及制剂

Country Status (3)

Country Link
JP (1) JPWO2024204380A1 (https=)
CN (1) CN120835873A (https=)
WO (1) WO2024204380A1 (https=)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5998135B2 (ja) * 2011-06-24 2016-09-28 株式会社カネカ 安定性に優れた還元型補酵素q10結晶
JP7330987B2 (ja) * 2018-08-30 2023-08-22 株式会社カネカ 安定性に優れた還元型補酵素q10結晶の製造方法
CN115087631B (zh) * 2020-02-12 2024-05-14 株式会社钟化 FormII型的还原型辅酶Q10结晶的制造方法

Also Published As

Publication number Publication date
JPWO2024204380A1 (https=) 2024-10-03
WO2024204380A1 (ja) 2024-10-03

Similar Documents

Publication Publication Date Title
US12109200B2 (en) Rifaximin
EP2791122B1 (en) Crystalline form of cabazitaxel and process for preparing the same
CN120835873A (zh) 还原型辅酶q10结晶及制剂
CN120858083A (zh) 还原型辅酶q10结晶及制剂
Fan et al. Solution-mediated phase transformation of cocrystals at the solid-liquid interface: Relationships between the supersaturation generation rate and transformation pathway
EP2029615B1 (en) A rpocess for the preparation of an oxaliplatin
CN109705076B (zh) 一种达格列净晶型、制备方法及其用途
JP7695993B2 (ja) FormII型の還元型補酵素Q10結晶又はその結晶性固体の製造方法
EP1478637B1 (en) Amorphous citalopram salts
EP3475261A1 (en) Crystalline calcium salt of (s)-2-(diphenylacetyl)-1,2,3,4-tetrahydro-6-methoxy-5-(phenylmethoxy)-3-isoquinoline carboxylic acid
HK40028413B (en) Crystal of 3,5-disubstituted benzene alkynyl compound
WO2026013573A1 (en) New salt forms of sabcomeline
CN116554255A (zh) 一种醋酸乌利司他晶型a的制备方法及药物组合物
JP2007521253A5 (https=)

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination